We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Orthopedic Medical Imaging Pioneer Acquires Exclusive Rights to Scoliosis Prognosis Algorithm

By MedImaging International staff writers
Posted on 13 Oct 2015
Print article
A company that leads in 2-D/3-D orthopedic medical imaging announced that it has acquired the rights to a worldwide license for a 2-D/3-D software that can predict the risk of adolescent patients with mild scoliosis developing severe deformities.

The software algorithm uses various clinical parameters obtained from patient reports to set a predictive score and help determine the risk of young patients with an early and mild scoliosis developing severe scoliosis.

The exclusive rights to the technology were secured by EOS imaging (Paris, France). The software uses 2-D and 3-D parameters from EOS imaging systems. Eight imaging centers equipped with EOS systems centers in the USA, Hong Kong, Singapore, Japan, France, and Canada will evaluate the use of the technology as a predictive tool, as part of a multicenter study.

The software will enable clinicians to predict the risk of severe scoliosis and help them choose between surgery and a brace as the best therapy. EOS imaging is also involved in research to improve the design of such braces using 3-D data of the spine, ribs, and body contours.

CEO of EOS imaging, Marie Meynadier, said, “This promising technology confirms the value of the 3D data naturally associated with EOS images in developing applications and services dedicated to orthopedic care pathways. Acquiring these exclusive rights is an integral part of our global strategy to offer doctors not only cutting-edge imaging technology, but also a full suite of software and services to help them in their therapeutic strategies and execution, to the greatest benefit to patients.”

Related Links:

EOS Imaging


New
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Digital Radiographic System
OMNERA 300M
NMUS & MSK Ultrasound
InVisus Pro
Silver Member
X-Ray QA Meter
T3 AD Pro

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.